Dr. Raman specializes in endoluminal and open vascular surgery.
Areas of clinical interest include treatment for carotid stenosis, abdominal and thoracic aortic aneurysms, aortoiliac occlusive disease, surgery for dialysis access, peripheral arterial disease, venous insufficiency and ulceration and varicose veins.
M.D., Columbia University, College of Physicians and Surgeons, 1998.
M.P.H., Columbia University, Mailman School of Public Health. 1998.
Internship, General Surgery, University of Pittsburgh Medical Center, 1998-1999.
Residency, General Surgery, University of Pittsburgh Medical Center, 1999-2006.
Fellowship, Vascular Surgery, Washington University in St. Louis, 2006-2007.
Center for Advanced Medicine
Heart and Vascular Center
4921 Parkview Place, Suite A, Floor 8
St. Louis, MO 63110
(314) 747-VASC (8272) or 1-877-799-0909
Fax: (314) 362-4615
Barnes-Jewish West County Hospital
Professional Building 1
1040 N. Mason Rd
Suite 120
Creve Coeur, MO
(314) 362-6460
(314) 362-6460
Raman KG, Sappington PL, Yang R, Levy RM, Prince JM, Liu S, Watkins SK, Schmidt AM, Billiar TR, Fink MP. The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol. 2006;291(4):G556-G565.
Raman KG, Barbato JE, Ozanich BA, Ifedigbo E, Otterbein LE, Tzeng E. Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide. Journal of Vascular Surgery. 2006;44(1):151-158.
Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in Type II diabetes mellitus. Am J Physiol Heart Circ Physiol. 2005;289(1):H228-H236.
Raman KG, Sappington PL, Yang R, Liu F, Otterbein LE, Schmidt AM, Fink MP, Billiar TR. Essential role of receptor for advanced glycation end products in the inflammatory response and mucosal injury following hemorrhagic shock. Journal of the American College of Surgeons. 2004;199(3S):S36-S37.
Raman KG, Shapiro RA, Tzeng E, Kibbe M. Adenovirus-mediated nitric oxide synthase gene transfer. Methods in Molecular Biology. 2004;279:225-234.
Raman KG, Layne S, Makaroun MS, Kelley ME, Rhee RY, Tzeng E, Muluk VS, Muluk SC. Disease progression in contralateral carotid artery is common after endarterectomy. Journal of Vascular Surgery. 2004;39(1):52-57.
Raman KG, Missig-Carroll N, Richardson T, Muluk SC, Makaroun MS. Color-flow duplex ultrasound scan versus computed tomographic scan in the surveillance of endovascular aneurysm repair. Journal of Vascular Surgery. 2003;38(4):645-651.
Raman KG, Tsai M, Ferran Jr. L, Fan L, Lindenberg N, Stern D, Berglund L, Huang LS, Schmidt AM. Genetically diabetic (db/db) transgenic mice overexpressing human apolipoprotein B (HuBTg) exhibit accelerated atherosclerosis. Circulation suppl. 1998;98:17 Abst. #2445, p. 465.
Park L*, Raman KG* (*co-authors), Lee KJ, Lu Y, Ferran Jr. L, Chow WS, Stern D, Schmidt AM. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE). Nature Medicine. 1998;4(9).
Raman KG, Lu Y, Tsai M, Ferran Jr. L, Chow WS, Berglund L, Huang LS, Schmidt AM. A model of accelerated atherosclerosis in diabetic mice overexpressing human apo B: Suppression by soluble receptor for advanced glycation end products. The FASEB Journal. 1998. Abstracts Part 1, Abst. #618, p. A106.
Raman KG, Radhakrishnan J, Valeri A, Chen JM, Benvenisty AI, Hardy MA. Toxicity of anticardiolipin antibody in hemodialysis vascular access failure. Owen H. Wangensteen Surgical Forum Volume XLVIII, 1997.
Raman KG, McCrudden KW, Lu Y, Ginsberg MD, Ferran Jr. L, Stern D, Huang LS, Schmidt AM. Diabetes in male human apo B transgenic mice results in accelerated atherosclerosis with minimal modification of lipid profile. Arteriosclerosis. 1997. Vol. 2, Abst. #9411, P. 111.
Park L, Raman KG, Lee KJ, Lu Y, Ginsberg MD, Ferran Jr. L, Stern D, Schmidt AM. A murine model of accelerated atherosclerosis: suppression by soluble receptor for advanced glycation end products. Circulation suppl. 1997;96:8 Abst. #3079, p. 550.
|
